Representative CT and PET/CT images of three patients with NSCLCs

Slides:

Advertisements

Similar presentations

Unexpected additional lung cancer in a patient with already known inflammatory myofibroblastic tumor detected on PET/CT Kaohsiung Veterans General Hospital.

Advertisements

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors by Lecia V. Sequist, Belinda A. Waltman, Dora Dias-Santagata,

Authors: Syed H. Jafri ¹, Angel I. Blanco¹, Bonnie A. Labdi², Shan Guo¹. UT Houston department of medicine, Division of Oncology Department of Pharmacy.

Fig. 9. Warthin's tumor, a 72-year-old man with supraglottic cancer. A

Fig F-fluoride positron emission tomography (PET) in atherosclerosis

A long-term survivor of non-small-cell lung cancer harboring concomitant EGFR mutation and ALK translocation Fumio Imamura, Takako Inoue, Madoka Kimura,

Fig. 2. High-resolution melting curves for exon 21 of the EGFR gene

Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma Kazuya Takamochi, MD, Shiaki Oh, MD,

Fig. 1. Abnormalities on chest imaging of the patient

Figure 1 Carotid artery inflammation detected using 18F-FDG-PET

Examples of functional imaging biomarkers in two DCA responders

Fig. 4. Primary human metastatic melanomas contain CCL21-expressing LECs, and expression of VEGFC positively correlates with hallmarks of tumor inflammation.

Fig. 1. IL-6 is associated with resistance to EGFR TKIs and is induced by stress hormones. IL-6 is associated with resistance to EGFR TKIs and is induced.

T790M Mutation-Positive NSCLC: A Multidisciplinary Case Conference

A, baseline and 4-week PET scan from patient 2 (MET c

Fig. 2. Mutational signature exposures in Taiwan HCCs and summary of AA signature mutations. Mutational signature exposures in Taiwan HCCs and summary.

Effects of highly concentrated SFN provided as BSE in T2D patients

Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.

Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.

β-ARs signal cooperatively with mutant EGFR and inactivate LKB1

Integrated positron emission tomography (PET)/computed tomography (CT)

Fig. 4. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive and HBeAg-negative chimpanzees. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive.

Fig. 4. Hydrogel particle size and gelation mechanism.

Uterine metastasis of lung adenocarcinoma revealed by the same epidermal growth factor receptor mutation in both lung and endometrial biopsies Noriko.

Fig. 4. Functional annotation of VUS in EGFR.

Fig. 1. Schematic representation of the MANO method.

Fig. 3. Frequencies of amino acids at critical PGT121 and contact sites in the SHIV-SF162P3 challenge stock. Frequencies of amino acids at critical.

Unexpected Small Bowel Intussusception Caused by Lung Cancer Metastasis on 18F- Fluorodeoxyglucose PET-CT Jeong Won Lee, MD, Seok-Ki Kim, MD, Ji Won Park,

Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.

Fig. 8. mRIPO elicits neutrophil influx followed by DC and T cell infiltration into tumors. mRIPO elicits neutrophil influx followed by DC and T cell infiltration.

Intravenous delivery of reovirus to primary and secondary brain tumors

Fig. 5. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic mice. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic.

Expression of CD36 and psap in a TMA of human ovarian cancer patients

Successful tissue collection in patients with relapse of EGFR-positive adenocarcinoma after EGFR-TKI treatment. Successful tissue collection in patients.

Increased ADMA in pregnancy is associated with SGA birth outcomes

Fig. 6. Effects of CD31-NP targeting in perfused human kidneys.

Fig. 5 A competent Fc is required for the antitumor immune response.

Dot plots of trisomic versus fetal fractions for cohorts 1 and 2

Fig. 7 Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors. Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors.

Fig. 1. Serum HBsAg, HBcrAg, and HBeAg reduction in human patients treated with a single dose of ARC-520. Serum HBsAg, HBcrAg, and HBeAg reduction in human.

Fig. 1. Generation of the ΔEx50 mouse model.

Fig. 5. Clinical data with BLU-285 confirm early evidence of activity in patients with diseases driven by KIT and PDGFRA activation loop mutations. Clinical.

Fig. 2 STED microscopy of isolated cardiomyocytes from mice treated with MP-rhodamine–loaded CaPs. STED microscopy of isolated cardiomyocytes from mice.

Fig. 2. Best model fits. Best model fits. Illustration of the best model fits for the (A) basic, (B) continuous, and (C) cluster models. See Table 1 and.

Metabolic response by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT). a) FDG PET/CT for patient 2 at baseline.

A) Coronal reconstruction of chest CT angiography images showing marked hypodensity of the left upper lobe. b) Coronal reconstruction of maximum intensity.

Fig. 5 EGFR mutation status of patients with NSCLC, detected by histological examination and ARMS PCR. EGFR mutation status of patients with NSCLC, detected.

Fig. 3. β-AR signaling induces IL-6 in NSCLC cells via activation of PKC and CREB. β-AR signaling induces IL-6 in NSCLC cells via activation of PKC and.

Fig. 5 Local gel scaffold for T cell memory response.

Fig. 3 M7824 inhibits tumor growth and metastasis and provides long-term antitumor immunity. M7824 inhibits tumor growth and metastasis and provides long-term.

Fig. 4. Improved tumor response to docetaxel in TNBC and trastuzumab in HER2-amplified PDX models with the addition of S Improved tumor response.

Fig. 7. NAC in breast cancer patients promotes TMEM assembly and increased MENAINV expression. NAC in breast cancer patients promotes TMEM assembly and.

Fig. 3. TKI sensitivity assessed by the MANO method.

Fig. 4. The effect of single-dose rozanolixizumab on the concentration of IgG subtypes in healthy subjects. The effect of single-dose rozanolixizumab on.

Fig. 2 In vitro and preclinical study with 18F-MPG.

Evaluation of clinical responses after infusion of CART19 cells

Fig F-FGln shows uptake in human gliomas undergoing progression.

Fig. 3 CSF1 is expressed in human melanoma.

Fig. 7 Analysis of the bacterial nidus within tissue abscesses by MALDI IMS demonstrates a paucity of calprotectin signal. Analysis of the bacterial nidus.

Fig. 3 Activation of freshly isolated CD4+ T cells from HIV-infected patients on ART selectively reverses baseline blocks to splicing, elongation, and.

Correlation of reovirus RNA/protein with proliferating tumor cells

Fig. 2. Clinically actionable somatic genomic alterations in various tumor types. Clinically actionable somatic genomic alterations in various tumor types.

Fig. 1 Molecular imaging of EGFR-activating mutation status for stratification of patients. Molecular imaging of EGFR-activating mutation status for stratification.

Hisa Shimojima et al. JACEP 2018;4:

Representative examples of estrogen receptor α and β immunohistochemical expression (top figures) and EGFR mutations (bottom figures) in lung adenocarcinomas.

Representative CT and PET/CT images of three patients with NSCLCs

Location of common clinically relevant mutations in EGFR

Fig. 2 In vitro and preclinical study with 18F-MPG.

Delineating cancer evolution with single-cell sequencing

Frequent coamplification of RTKs in MET-amplified EGC

Presentation transcript:

Fig. 4 Representative CT and PET/CT images of three patients with NSCLCs. Representative CT and PET/CT images of three patients with NSCLCs. (A) Patient (number 3) with an EGFR exon 19 E746-A750 deletion who did not receive EGFR-TKI treatment, with a tumor in the upper right lobe of the lung [red arrows; 18F-MPG SUVmax (maximum standard uptake value) of 3.93]. (B) Patient (number 36) with an EGFR exon 21 L858R point mutation, 15 days after gefitinib treatment. Tumor in the upper right lung lobe (red arrows; 18F-MPG SUVmax of 3.60) and spinal metastasis (yellow arrows; 18F-MPG SUVmax of 2.11) were observed both on 18F-MPG and 18F-FDG images. (C) Patient (number 54) with wild-type EGFR who did not receive EGFR-TKI treatment. Tumor in the left hilum (red arrows; 18F-MPG SUVmax of 1.38) was prominently observed on the 18F-MPG image. Xilin Sun et al., Sci Transl Med 2018;10:eaan8840 Published by AAAS